Clinical Trial

Privosegtor Investigation in Optic Neuropathies Efficacy Evaluation Research

Study acronym: PIONEER-1
Recruiting Phase 3
View on ClinicalTrials.gov →
Summary
The goal of this clinical trial is to evaluate the safety and efficacy of privosegtor, a neuroprotective candidate, in patients diagnosed with optic neuritis (ON). Researchers will compare privosegtor and the standard of care (methylprednisolone) to a placebo and standard of care (methylprednisolone).
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2026-05-28.
Trial Details
NCT Number NCT07623668
Lead Sponsor Oculis
Conditions Optic Neuritis
Enrollment 210 participants
Start Date 2026-05-28
Primary Completion 2027-12 (estimated)
Study Completion 2028-12 (estimated)
Updated on ClinicalTrials.gov 2026-08-14